BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 28142127)

  • 1. The Sequential Probability Ratio Test: An efficient alternative to exact binomial testing for Clean Water Act 303(d) evaluation.
    Chen C; Gribble MO; Bartroff J; Bay SM; Goldstein L
    J Environ Manage; 2017 May; 192():89-93. PubMed ID: 28142127
    [TBL] [Abstract][Full Text] [Related]  

  • 2. On the efficiency of the independent segments procedure: A direct comparison with sequential probability ratio tests.
    Erdfelder E; Schnuerch M
    Psychol Methods; 2021 Aug; 26(4):501-506. PubMed ID: 34726467
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Using transcription-based detectors to emulate the behavior of sequential probability ratio-based concentration detectors.
    Chou CT
    Phys Rev E; 2022 Nov; 106(5-1):054403. PubMed ID: 36559424
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Controlling decision errors with minimal costs: The sequential probability ratio t test.
    Schnuerch M; Erdfelder E
    Psychol Methods; 2020 Apr; 25(2):206-226. PubMed ID: 31497982
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Statistical assessment of violations of water quality standards under Section 303(d) of the clean water act.
    Smith EP; Ye K; Hughes C; Shabman L
    Environ Sci Technol; 2001 Feb; 35(3):606-12. PubMed ID: 11351736
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficiency in sequential testing: Comparing the sequential probability ratio test and the sequential Bayes factor test.
    Stefan AM; Schönbrodt FD; Evans NJ; Wagenmakers EJ
    Behav Res Methods; 2022 Dec; 54(6):3100-3117. PubMed ID: 35233752
    [TBL] [Abstract][Full Text] [Related]  

  • 7. How probability survey data can help integrate 305(b) and 303(d) monitoring and assessment of state waters.
    Brown BS; Detenbeck NE; Eskin R
    Environ Monit Assess; 2005 Apr; 103(1-3):41-57. PubMed ID: 15861986
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Erratum: High-Throughput Identification of Resistance to Pseudomonas syringae pv. Tomato in Tomato using Seedling Flood Assay.
    J Vis Exp; 2023 Oct; (200):. PubMed ID: 37851522
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sequential clinical trials for normal variates using interval composite hypotheses.
    Lachin JM
    Biometrics; 1981 Mar; 37(1):87-101. PubMed ID: 7248445
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of competency in clinical measurement: comparison of two forms of sequential test and sensitivity of test error rates to parameter choice.
    Sims AJ; Keltie K; Burn J; Robson SC
    Int J Qual Health Care; 2013 Jul; 25(3):322-30. PubMed ID: 23559422
    [TBL] [Abstract][Full Text] [Related]  

  • 12. On Computing the Key Probability in the Stochastically Curtailed Sequential Probability Ratio Test.
    Huebner AR; Finkelman MD
    Appl Psychol Meas; 2016 Mar; 40(2):142-156. PubMed ID: 29881044
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transitioning sediment quality assessment into regulations: Challenges and solutions in implementing California's sediment quality objectives.
    Beegan C; Bay SM
    Integr Environ Assess Manag; 2012 Oct; 8(4):586-8. PubMed ID: 22987517
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Statistical rules for safety monitoring in clinical trials.
    Martens MJ; Logan BR
    Clin Trials; 2024 Apr; 21(2):152-161. PubMed ID: 37877375
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessing the US Clean Water Act 303(d) listing process for determining impairment of a waterbody.
    Keller AA; Cavallaro L
    J Environ Manage; 2008 Mar; 86(4):699-711. PubMed ID: 17270339
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Application of the triangular test to phase II cancer clinical trials.
    Bellissant E; Benichou J; Chastang C
    Stat Med; 1990 Aug; 9(8):907-17. PubMed ID: 2218193
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association Between California's State Insurance Gender Nondiscrimination Act and Utilization of Gender-Affirming Surgery.
    Schoenbrunner A; Beckmeyer A; Kunnath N; Ibrahim A; Pawlik TM; Venkataramani A; Kuzon WM; Diaz A
    JAMA; 2023 Mar; 329(10):819-826. PubMed ID: 36917051
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Continuous and group sequential conditional probability ratio tests for phase II clinical trials.
    Tan M; Xiong X
    Stat Med; 1996 Oct; 15(19):2037-51. PubMed ID: 8896138
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sequential Probability Ratio Testing with Power Projective Base Method Improves Decision-Making for BCI.
    Liu R; Wang Y; Wu X; Cheng J
    Comput Math Methods Med; 2017; 2017():2948742. PubMed ID: 29348781
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of Churn in Coverage Among California's Health Insurance Marketplace Enrollees.
    Wolf E; Slosar M; Menashe I
    JAMA Health Forum; 2022 Dec; 3(12):e224484. PubMed ID: 36459160
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.